The Povidone Iodine molecule has a broad spectrum antimicrobial action1,2 and has been proven to be effective against MRSA3-5.
INADINE™ minimises adherence to the wound bed, therefore reducing the risk of damage to the granulation tissue at dressing removal2, and in clinical practice has been shown to reduce pain for patients6,7.
As PVP–I is released from INADINE™ the dressing will change colour from orange to white. The colour change provides an indicator of how frequently dressings should be changed preventing unnecessary dressing changes, when compared to other dressings1. This could improve cost effectiveness in treatment.
C1675 Nov 2013
1. Han K.H et al. Management of partial skin thickness burn wounds with INADINE™ dressings. Burns 1989 Vol.15 (6) 399-402
2. Sibbald, R.G. et al. Iodine Made Easy. Wounds International 2011; 2(2)
3. Langley, S.R.N. INADINE™ wound dressings speed healing, reduce patient discomfort and cuts costs by almost 40%. Burns 1989 Vol.15
4. Vowden, P. and Cooper, R.A . An integrated approach to managing wound infection Position Document: Management of wound infection. European Wound Management Association (EWMA). London: MEP Ltd, 2006
5. Balmforth, V. INADINE Povidone Iodine non adherent dressing as a treatment for superficial wounds infected with Methicillin resistant Staphylococcus aureus. Case Study, 1996
6. Gordon, J. Clinical significance of methicillin-sensitive and methicillin resistant Staphylococcus aureus in UK hospitals and the relevance of povidone iodine in their control. Postgrad. Med J. 1993, 69(3):106-116
7. Campbell, N. and Campbell, D. et al. Evaluation of a non-adherent, povidone–iodine dressing in a case series of chronic wounds. Journal of Wound Care, Vol 22, No 8, August 2013.